$AMGN News Small health companies see large gains on a

New Post Public Reply Private Reply Replies (0) Message Board

Aug 2, 2014 at 12:35 PM

$AMGN News

Small health companies see large gains on a big earnings day 5:34 p.m. July 30, 2014 - Russ Britt
Twitter, U.S. Steel soar; Buffalo Wild Wings are burned 4:26 p.m. July 30, 2014 - Sue Chang
Edwards, Hospira rise as health-care companies see strong earnings 1:08 p.m. July 30, 2014 - Russ Britt
Amgen shares hit record on cost-cutting plans 10:50 a.m. July 30, 2014 - Russ Britt
Twitter shines; Fed statement and GDP due today 4:38 a.m. July 30, 2014 - MarketWatch
Amgen plans to cut up to 2,900 jobs 9:04 p.m. July 29, 2014 - MarketWatch.com
Twitter soars 33% in after hours as results surprise on upside 4:56 p.m. July 29, 2014 - Sue Chang
Amgen share climb 3.6% in after-hours trade after raised EPS outlook 4:38 p.m. July 29, 2014 - Tomi Kilgore
Amgen to cut up to 15% of workforce, ups EPS view 4:37 p.m. July 29, 2014 - MarketWatch.com
Amgen Q2 FactSet sales consensus $4.9 bln 4:31 p.m. July 29, 2014 - Jim Jelter
Amgen Q2 sales $5.18 bln vs $4.68 bln a year ago 4:31 p.m. July 29, 2014 - Jim Jelter
Amgen Q2 FactSet EPS consensus $2.07 4:30 p.m. July 29, 2014 - Jim Jelter
Amgen Q2 EPS $2.01 4:29 p.m. July 29, 2014 - Jim Jelter
The Fed meets; Twitter and Amex report results 4:32 a.m. July 29, 2014 - MarketWatch
The market in a minute: What will GDP mean for the market? 12:47 p.m. July 28, 2014 - The Trading Deck
PetSmart gains on Jana stake; Lorillard rallies 1:37 p.m. July 3, 2014 - Sue Chang
Synnex shares decline as outlook edges earnings 5:20 p.m. July 2, 2014 - Wallace Witkowski
Cytokinetics plunges 60% after Lou Gehrig's disease drug fails test 10:26 a.m. April 25, 2014 - Russ Britt
Apple, Facebook stuck in red ahead of earnings 3:03 p.m. April 23, 2014 - Sue Chang
Game day for Facebook and Apple, volume 'signalling the nasty' 6:50 a.m. April 23, 2014 - Barbara Kollmeyer

3 Stocks Reiterated As A Buy: VZ, QCOM, AMGN 12:44 p.m. Aug. 1, 2014 - TheStreet.com
Do Layoffs in Biotech Send the Right Message? 9:45 a.m. Aug. 1, 2014 - 247WallSt.com
Amgen Makes the Cut 12:25 p.m. July 31, 2014 - Barrons.com
Stock Market News for July 31, 2014 - Market News 10:10 a.m. July 31, 2014 - Zacks.com
Biotech Earnings Put These ETFs in Focus - ETF News And Commentary 10:01 a.m. July 31, 2014 - Zacks.com
Nasdaq Threatens to Break Double-Top 9:11 p.m. July 30, 2014 - InvestorPlace.com
Drug Firms Buy $67.5 Million Voucher to Speed FDA Review 7:21 p.m. July 30, 2014 - The Wall Street Journal Interactive Edition
Amgen - Continued Appeal With Shares Trading At Fresh All-Time Highs 5:25 p.m. July 30, 2014 - Seeking Alpha
U.S. Stocks End Mixed 4:31 p.m. July 30, 2014 - The Wall Street Journal Interactive Edition
Stock Market Today: Stocks Mixed as Fed Cuts Bond Buying to $25 Billion 4:31 p.m. July 30, 2014 - TheStreet.com
Stocks Mixed Despite Better-Than-Expected GDP 3:43 p.m. July 30, 2014 - benzinga.com
Stock Market Today: Stocks Slip Ahead of Fed Policy Announcement 1:50 p.m. July 30, 2014 - TheStreet.com
Amgen Price Target Raised by Various Analysts 12:42 p.m. July 30, 2014 - benzinga.com
Amgen Pleases the Street -- but Will Layoffs Keep Critics at Bay? 11:05 a.m. July 30, 2014 - TheStreet.com
Amgen Restructuring Plan, Q2 Earnings Send Stock Up 10:20 a.m. July 30, 2014 - Investors Business Daily
Stock Market News for July 30, 2014 - Market News 10:10 a.m. July 30, 2014 - Zacks.com
Trade-Ideas: Amgen (AMGN) Is Today's New Lifetime High Stock 9:45 a.m. July 30, 2014 - TheStreet.com
Amgen Beats on Q2 Earnings & Revs, Ups View & Plans Job Cuts - Analyst Blog 9:20 a.m. July 30, 2014 - Zacks.com
Will This Price Target Increase Help Amgen (AMGN) Stock Today? 9:02 a.m. July 30, 2014 - TheStreet.com
Amgen Reports Stellar Earnings, Raises Guidance 8:00 a.m. July 30, 2014 - benzinga.com

RBCC 3D Bioprinting Partner Awarded Prestigious Grant 6:54 a.m. July 31, 2014 - BusinessWire - BZX
Resilinc Named 2014 Great Supply Chain Partner by SupplyChainBrain 10:00 a.m. July 30, 2014 - Marketwire
Global Women%s Health Market 2014-2018 6:20 p.m. July 28, 2014 - PR Newswire - PRF
Amgen Announces 2014 Third Quarter Dividend 4:00 p.m. July 25, 2014 - PR Newswire - PRF
Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR® (sorafenib) in Patients with Advanced Breast Cancer 2:30 a.m. July 25, 2014 - PR Newswire - PRF
Amgen Announces Webcast of 2014 Second Quarter Financial Results 4:00 p.m. July 24, 2014 - PR Newswire - PRF
Surveyed U.S. and EU5 Dermatologists Indicate that Short-Term and Long-Term Effects on Psoriatic Plaque Clearance are Two Attributes that Most Strongly Influence Prescribing Decisions in Moderate to Severe Psoriasis 2:00 p.m. July 24, 2014 - PR Newswire - PRF
Amgen's Evolocumab is Set to Become the Clinical Gold-Standard Among Statin Add-On Therapies for Dyslipidemia 10:00 a.m. July 21, 2014 - PR Newswire - PRF
Colorado BioScience Association Recognizes Amgen Foundation’s $25,000 Investment in STEM Education in Colorado’s Classrooms 9:00 a.m. July 21, 2014 - BusinessWire - BZX
Amgen Announces Positive Phase 3 Results for AMG 416 for the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease Receiving Hemodialysis 4:01 p.m. July 17, 2014 - PR Newswire - PRF
Global Pharmaceutical Survey 2013-2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry 4:27 p.m. July 15, 2014 - PR Newswire - PRF
Critical Alerts For Citigroup, BlackBerry, RF Micro Devices, Amgen, and Microsoft Released By InvestorsObserver 9:31 a.m. July 15, 2014 - PR Newswire - PRF
Biotech Stocks Highlight -- Research on Celgene, Inovio Pharma, Amgen, and Array BioPharma 6:40 a.m. July 9, 2014 - PR Newswire - PRF
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
BIND Therapeutics Announces Completion of Collaboration Agreement with Amgen 4:01 p.m. July 2, 2014 - BusinessWire - BZX
Amgen Receives FDA Breakthrough Therapy Designation For Investigational BiTE® Antibody Blinatumomab In Acute Lymphoblastic Leukemia 8:09 a.m. July 1, 2014 - PR Newswire - PRF
Deciphera Pharmaceuticals Appoints Oliver Rosen M.D. as Chief Medical Officer 8:30 a.m. June 30, 2014 - BusinessWire - BZX
Leadership Appointments, Acquisitions, Orphan Drug Designations, Strategic Collaborations, and Technical Updates - Analyst Notes on Aerie, Medical Action, INSYS, Novadaq and Foundation Medicine 6:10 a.m. June 30, 2014 - PR Newswire - PRF
Collaborations, Clinical Study Results, and Laboratory Inspection Clearance - Analyst Notes on Amgen, Regeneron, Lexicon, WuXi PharmaTech and ImmunoGen 6:40 a.m. June 25, 2014 - PR Newswire - PRF
Critical Alerts For Walt Disney, Amgen, 3D Systems, Microsoft, and Lowe's Released By InvestorsObserver 9:31 a.m. June 23, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Agroz's Big Leap: New Supply Deal in Malaysia

Agroz Inc. Executes a Game-Changing Deal If anyone thought the ag tech players were sitting idle, think again. Agroz Inc., noted for their innovative controlled-environment agriculture, just inked a pivotal deal with Harvest Hive in Malaysia. It's not just a nod to expansion—it's a strategic leap into the big leagues. Picture this: Harvest Hive's sprawling 500-acre farm...

Aflac's $200M Milestone in Cancer Charity Support

Pioneering Efforts Across Decades Here’s an effort that bucks the usual corporate talk. Aflac, the supplemental insurance giant, isn’t just mumbling about its mission; it's doing the heavy lifting in the fight against childhood cancer and blood disorders. With over $200 million in contributions poured into the cause over more than 30 years, they're putting the capital...

RevSystems Joins Elite OpenAI Partner Network

RevSystems Inks Deal with OpenAI Partner Network In the latest shuffle of the AI advisory deck, RevSystems just found itself elbowing into the exclusive OpenAI Partner Network. Based out of New York, RevSystems has carved a niche by spinning tech wizardry into tangible business results. Their new status as an OpenAI Select Partner puts them on a playing field where AI...

Health Net's $2M Boost for Stanislaus Affordable Housing

Joining the Fight Against California’s Housing Crisis Well, I'll be the first to say it's a breath of fresh air when a healthcare beast like Health Net starts investing in something as critical as affordable housing. This is no drop in the bucket—two million dollars is quite the commitment to fix some of the mess that’s been brewing in Stanislaus County, California....

From Kitchen Experiment to U.S. Debut Here's a story that barely fits the tight mold of your typical business textbook. Hair Syrup, born from the brain of a university student tinkering at her kitchen table, is about to make waves across the pond. Lucie Macleod did what many dream of—she took a DIY hair oil project and spun it into a multimillion-dollar brand, now set...

Sacrifice Unending: 9/11's Lingering Health Toll

The Unseen Toll of 9/11 on the Firefighter Community Two and a half decades since that fateful morning of September 11, 2001, we're staring at a grim reality. The heroic souls of the New York City Fire Department (FDNY)—those who ran toward peril when others ran away—are still paying the price. Incredibly, more than 400 FDNY members have succumbed to World Trade...

WNET's 25th Anniversary 9/11 Tribute: Stories and Lessons

Reflecting on a Dark Day with WNET's Programming Nothing quite hits you like the anniversary of a colossal tragedy. The memories of September 11, 2001, remain etched in the urban landscape of New York City, and this year marks 25 years since that heart-wrenching day. The WNET Group steps up to the plate with a comprehensive slate of programming aimed at honoring the...

Cove Capital Secures $9.96M for Debt-Free Logistics DST

Unpacking Cove Capital's Latest Victory Cove Capital Investments has pulled off another coup, raising a hefty $9,964,510 for its Cove Essential Net Lease Industrial 108 DST. It's a Regulation D, Rule 506(c) offering, now fully subscribed, spotlighting a debt-free investment ethos and a rock-solid logistics site in Anchorage, Alaska. Strategic Facility Anchoring Investment...

Are FULC, WEAV, TECH Shareholders Getting a Raw Deal?

Pocketing Insider Gains Amidst Shareholder Concerns Let me tell you, it smells like another day in the financial jungle where insiders might be feasting while the regular Joe shareholders are left nibbling on crumbs. Fulcrum Therapeutics, Weave Communications, and Bio-Techne are in the crosshairs for deals that may favor those on the inside track over you and me, the...

EFSI Shareholders on Alert Amid M&A Deal Scrutiny

Eagle Financial Services Under the Microscope A buzz is picking up in the world of mergers and acquisitions, and this time, it's Eagle Financial Services, Inc. (NASDAQ: EFSI) caught in the crosshairs. What's the chatter all about? Well, it looks like Juan Monteverde and his crew over at Monteverde & Associates PC have set their sights on Eagle's proposed sale to John...